Virtual reality, real injuries: OSU study shows how to reduce physical risk in VR
(Oregon State University) Carpal tunnel, stiff shoulders, eye-strain headaches -- these are all well-known side effects of prolonged computer use. But what happens when you step away from the desktop and into virtual reality?A recent study assessed how some common virtual reality movements contribute to muscle strain and discomfort. It's an effort to ensure future user safety in this fast-growing technology that's used not only for gaming, but also increasingly for education and industrial training. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 7, 2020 Category: Biology Source Type: news

'My word against his': 28 women sexually assaulted by Calgary doctor, court hears during guilty plea
From MS to seizures to chronic migraines; the women who were referred to Calgary neurologist Dr. Keith Hoyte faced a host of medical conditions and were hopeful he could help. Instead he sexually assaulted dozens of victims over a 30-year period. (Source: CBC | Health)
Source: CBC | Health - January 6, 2020 Category: Consumer Health News Tags: News/Canada/Calgary Source Type: news

New Hope for Migraine Sufferers
There are now a number of medications that may prevent or alleviate migraines, as well as a wearable nerve-stimulating device that can be activated by a smartphone. (Source: NYT Health)
Source: NYT Health - January 6, 2020 Category: Consumer Health News Authors: Jane E. Brody Tags: Migraine Headaches Drugs (Pharmaceuticals) Brain Nerves and Nervous System Source Type: news

Acute Migraine Drug Hits Co-primary Endpoints in Phase 3 Trial Acute Migraine Drug Hits Co-primary Endpoints in Phase 3 Trial
The novel drug AXS-07 met the primary endpoints of freedom from acute migraine pain and most bothersome symptom, as well as key secondary outcomes, in top-line results of the MOMENTUM trial.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - January 3, 2020 Category: Internal Medicine Tags: Neurology & Neurosurgery News Source Type: news

Medical News Today: Fragmented sleep may trigger migraine 2 days later
The largest prospective study to date to look at sleep and migraine risk using objective measurements of sleep finds an intriguing link between the two. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 2, 2020 Category: Consumer Health News Tags: Headache / Migraine Source Type: news

Rhythmicity of cluster headache
(International Headache Society) Although it is known that CH patients exhibit circadian rhythmicity of attacks, new data add a new feature with regard to the rhythmicity of attacks throughout the disease course. The time predilection of attacks seems to be non-linear, with nighttime predilection at the early phase of disease course, with a progressive increase of daytime predilection, then a return to nighttime predilection at the late phase of the period observed in the disease course. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - January 2, 2020 Category: Biology Source Type: news

Improved NHS migraine care will ease burden on hospitals
Some 16,500 emergency admissions will be saved using new diagnosis and treatment plan Related items fromOnMedica Online triage ‘not a solution’ to GP workload pressures GPs need more time to treat complex needs Cost is main barrier to adoption of electronic records Patients with multiple health problems make up most GP consultations Huge hospital waits add to GPs ’ workload, warns top GP (Source: OnMedica Latest News)
Source: OnMedica Latest News - January 2, 2020 Category: UK Health Source Type: news

Improved NHS migraine care to cut hospital stays
Migraine sufferers will benefit from better diagnosis and care, which will also spare the NHS the headache of 16,500 avoidable emergency hospital admissions every year. (Source: NHS Networks)
Source: NHS Networks - January 2, 2020 Category: UK Health Source Type: news

FDA approves new treatment for adults with migraine
The U.S. Food and Drug Administration approved Ubrelvy (ubrogepant) tablets for the acute (immediate) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. Ubrelvy is not indicated for the preventive treatment of migraine. (Source: World Pharma News)
Source: World Pharma News - January 1, 2020 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

Paracetamol and ibuprofen: Can you take them together? Doctor's advice on taking both
PARACETAMOL and ibuprofen are both used to treat pain, from achy body parts to headaches. But is it safe to take both together - does taking the two at the same time offer more benefits or is it dangerous? (Source: Daily Express - Health)
Source: Daily Express - Health - January 1, 2020 Category: Consumer Health News Source Type: news

Hangover cure: Best food, drink and supplements to reduce your symptoms
HANGOVERS can bring on splitting headaches, feeling sick, dizziness and dehydration, making going about your day extremely difficult. So what are the best cures to relieve these symptoms? Certain foods, drinks and supplements have proven effective. (Source: Daily Express - Health)
Source: Daily Express - Health - January 1, 2020 Category: Consumer Health News Source Type: news

Monthly News Roundup - December 2019
FDA OKs Ubrelvy as First Oral Gepant for Migraine Treatment Migraine headache is a neurological disease with incapacitating symptoms that impacts 31 million Americans. In response, this month the FDA approved Ubrelvy (ubrogepant) from Allergan for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 1, 2020 Category: Pharmaceuticals Source Type: news

Combining neurologic and blood pressure drugs reduces breast tumor development in mice
(Georgetown University Medical Center) Adding a medication used to treat epilepsy, bipolar disorder and migraines to a blood pressure medicine reversed some aspects of breast cancer in the offspring of mice at high risk of the disease because of the high fat diet fed to their mothers during pregnancy. Conversely, this treatment combination increased breast cancer development in the offspring whose mothers had not been fed a high fat diet during pregnancy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 30, 2019 Category: International Medicine & Public Health Source Type: news

Sleep Disturbances May Trigger Migraine
Title: Sleep Disturbances May Trigger MigraineCategory: Health NewsCreated: 12/26/2019 12:00:00 AMLast Editorial Review: 12/27/2019 12:00:00 AM (Source: MedicineNet Migraine General)
Source: MedicineNet Migraine General - December 27, 2019 Category: Neurology Source Type: news

On nitroglycerin, cardiovascular homeostasis and...bam, migraine!
(International Headache Society) Researchers in Leiden, The Netherlands, found an exaggerated cardiovascular response to nitroglycerin infusion in migraine patients, suggesting an elevated systemic sensitivity to this compound in this population. Also, corroborating previous studies, nitroglycerin was shown to be a consistent migraine-provoking substance. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 27, 2019 Category: International Medicine & Public Health Source Type: news

Sleep Disturbances May Trigger Migraine
THURSDAY, Dec. 26, 2019 -- Sleep disturbances appear to be a trigger for migraine headaches, according to a new study. " We found that low sleep efficiency, which is the amount of time you're awake in bed when you're trying to sleep, was associated... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 26, 2019 Category: General Medicine Source Type: news

Middle East respiratory syndrome coronavirus (MERS-CoV) – Qatar
On 5 December 2019, the National IHR Focal Point for Qatar reported three laboratory-confirmed cases of Middle East respiratory syndrome (MERS-CoV) infection to WHO. The first case-patient (case #1) is a 67-year-old female from Doha, Qatar. She developed fever, cough, shortness of breath and headache on 23 November 2019, and presented to a hospital on 25 November. On 27 November, she went to the same hospital for follow up. However, on 28 November, her condition worsened and she was admitted to the hospital. A nasopharyngeal swab was collected on 28 November and tested positive for MERS-CoV by reverse-transcriptase polymer...
Source: WHO Disease Outbreaks - December 26, 2019 Category: Infectious Diseases Tags: news Source Type: news

With New FDA Approval, The Migraine Medication Revolution Continues
The FDA's approval of Ubrelvy is the next step in a bigger trend of new migraine medications. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 24, 2019 Category: Pharmaceuticals Authors: Leah Rosenbaum, Forbes Staff Source Type: news

New Migraine Treatment Relieves Pain In As Little As 4 Hours
What was once a debilitating condition may now be easily and quickly treatable thanks to a recent FDA announcement on the approval of a new migraine treatment. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 24, 2019 Category: Pharmaceuticals Authors: Dana Dovey, Contributor Source Type: news

New Migraine Treatment Relieves Pain In As Little As 2 Hours
What was once a debilitating condition may now be easily and quickly treatable thanks to a recent FDA announcement on the approval of a new migraine treatment. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 24, 2019 Category: Pharmaceuticals Authors: Dana Dovey, Contributor Source Type: news

FDA Approves New Drug For Migraine Sufferers
(CNN) — The US Food and Drug Administration on Monday announced the approval of a drug called ubrogepant for the acute treatment of migraine, which could be a new option for people who can’t take or don’t respond to migraine medications currently on the market. The drug will be sold under the name Ubrelvy by the pharmaceutical company Allergan. It is considered effective for migraine with or without aura, referring to the sensory or visual disturbances that occur among roughly a third of migraine sufferers. “Ubrelvy represents an important new option for the acute treatment of migraine in adults, as...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 24, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston FDA Migraines Source Type: news

Novel Treatments Are Reshaping Migraine Treatment, Prevention Novel Treatments Are Reshaping Migraine Treatment, Prevention
Dr Christoph Diener on the advantages that ditans, CGRP antagonists, and monoclonal antibodies have over earlier treatments.Medscape Neurology (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - December 24, 2019 Category: Neurology Tags: Neurology & Neurosurgery Commentary Source Type: news

FDA Approves New Type of Drug to Treat Migraines
The FDA approved a new treatment option for migraine patients who cannot get relief from existing medications once an attack strikes. (Source: WebMD Health)
Source: WebMD Health - December 24, 2019 Category: Consumer Health News Source Type: news

FDA Approves New Type of Drug to Treat Migraines
Title: FDA Approves New Type of Drug to Treat MigrainesCategory: Health NewsCreated: 12/23/2019 12:00:00 AMLast Editorial Review: 12/24/2019 12:00:00 AM (Source: MedicineNet Migraine General)
Source: MedicineNet Migraine General - December 24, 2019 Category: Neurology Source Type: news

FDA approves new drug for migraine sufferers
The US Food and Drug Administration on Monday announced the approval of a drug called ubrogepant for the acute treatment of migraine, which could be a new option for people who can't take or don't respond to migraine medications currently on the market. (Source: CNN.com - Health)
Source: CNN.com - Health - December 24, 2019 Category: Consumer Health News Source Type: news

Hepatitis gene therapy leads Bay Area trio of year-end FDA approval requests
Approaching the end of long drug-development journeys, these three Bay Area companies formally asked the FDA to approve potential treatments for hemophilia A, anemia in chronic kidney disease patients and migraines. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 23, 2019 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

Hepatitis gene therapy leads Bay Area trio of year-end FDA approval requests
Approaching the end of long drug-development journeys, these three Bay Area companies formally asked the FDA to approve potential treatments for hemophilia A, anemia in chronic kidney disease patients and migraines. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - December 23, 2019 Category: Biotechnology Authors: Ron Leuty Source Type: news

FDA OKs Ubrogepant (Ubrelvy) for Acute Migraine Treatment FDA OKs Ubrogepant (Ubrelvy) for Acute Migraine Treatment
Ubrogepant is the first drug in the class of oral calcitonin gene-related peptide receptor antagonists approved for the acute treatment of migraine.FDA Approvals (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - December 23, 2019 Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news

Allergan's acute migraine treatment wins U.S. FDA approval
The U.S. Food and Drug Administration said on Monday it had approved Allergan Plc's drug for relieving migraine headaches after their onset. (Source: Reuters: Health)
Source: Reuters: Health - December 23, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

FDA Approves Ubrelvy (ubrogepant) for the Acute Treatment of Migraine
DUBLIN, Dec. 23, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for Ubrelvy (ubrogepant) for the acute treatment of migraine with or without... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - December 23, 2019 Category: Drugs & Pharmacology Source Type: news

FDA approves new treatment for adults with migraine
FDA approves Ubrelvy (ubrogepant) tablets for the acute treatment of migraine with or without aura in adults. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - December 23, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news

FDA Approves New Type of Drug, Ubrogepant (Ubrelvy), to Treat Migraines
MONDAY, Dec. 23, 2019 -- Migraine sufferers who cannot get relief from existing medications have a new treatment option, the U.S. Food and Drug Administration announced Monday. The pill, called ubrogepant (Ubrelvy) is for the immediate treatment... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 23, 2019 Category: General Medicine Source Type: news

FDA Approves New Type of Drug to Treat Migraines
MONDAY, Dec. 23, 2019 -- Migraine sufferers who cannot get relief from existing medications have a new treatment option, the U.S. Food and Drug Administration announced Monday. The pill, called ubrogepant (Ubrelvy) is for the immediate treatment " of... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 23, 2019 Category: General Medicine Source Type: news

Man, 39, is diagnosed with syphilis in his EYES after going to hospital with a headache
The patient was treated at Sydney Eye Hospital in Australia and a doctor said his case was one of only three exactly like it which have been reported. (Pictured: A photo of the inside of his eye). (Source: the Mail online | Health)
Source: the Mail online | Health - December 23, 2019 Category: Consumer Health News Source Type: news

Migraine history and recurrence in military pilot applicants - Hesselbrock RR, Haynes JT.
BACKGROUND: Migraine is a common condition with features that can adversely impact aviation activities. The diagnosis of migraine is often compatible with civil aviation training, but is much more concerning for military pilot applicants. A history ... (Source: SafetyLit)
Source: SafetyLit - December 23, 2019 Category: International Medicine & Public Health Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

Different clinical phenotypes of persistent post-traumatic headache exhibit distinct sensory profiles - Levy D, Gruener H, Riabinin M, Feingold Y, Schreiber S, Pick CG, Defrin R.
INTRODUCTION: Persistent post-traumatic headache remains a poorly understood clinical entity. Although there are currently no accepted therapies for persistent post-traumatic headache, its clinical symptoms, which primarily resemble those of migraine or te... (Source: SafetyLit)
Source: SafetyLit - December 23, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Sleep Fragmentation Linked to Odds of Migraine
MONDAY, Dec. 23, 2019 -- Sleep fragmentation, defined by low sleep efficiency, is associated with increased odds of migraine a day later, but there is no temporal association for short sleep duration and low sleep quality with migraine, according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 23, 2019 Category: Pharmaceuticals Source Type: news

Packaged Hard-Boiled Eggs Linked To Deadly Listeria Outbreak, CDC Warns
(CNN) — A deadly, multistate outbreak of Listeria infections has been linked to packaged hard-boiled eggs, and retailers and consumers are warned not to serve, sell, use or consume the products. The peeled eggs were packaged in plastic pails by Almark Foods in Gainesville, Georgia, according the Centers for Disease Control and Prevention, which along with the US Food and Drug Administration is investigating. They were sold nationwide to food service operators, so consumers likely would find them in a store or a restaurant, the CDC said. Four of seven people who reported infections across five states have been hospita...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 19, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Syndicated CBSN Boston CNN Listeria Source Type: news

Lilly Announces the Launch of TRIUMPH, the First, Long-Term, Real-World Evidence Study of Emgality(R) (galcanezumab-gnlm)
In TRIUMPH all treatment decisions will be determined exclusively by patients and physicians, providing important data about the comparative effectiveness of migraine preventive treatments in a real-world population - a current gap in the field of migraine... Biopharmaceuticals, Neurology Eli Lilly, Emgality, galcanezumab-gnlm, Migraine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - December 18, 2019 Category: Pharmaceuticals Source Type: news

Medical News Today: What can cause an afternoon headache?
Many people experience headaches in the afternoon. Common causes include dehydration, muscle tension, caffeine, hunger, alcohol, and eyestrain. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 18, 2019 Category: Consumer Health News Tags: Headache / Migraine Source Type: news

' Suicide Headaches' Drive Doc to Clinical Trial'Suicide Headaches' Drive Doc to Clinical Trial
Dr Richard Isaacson discusses his personal experience with cluster headaches and the benefits of enrolling in a clinical trial.Medscape Neurology (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - December 17, 2019 Category: Emergency Medicine Tags: Neurology & Neurosurgery Commentary Source Type: news

Biohaven Pharma says treatment for acute migraine succeeds in study
Biohaven Pharmaceutical Holding Company Ltd said on Tuesday two doses of its experimental treatment for acute migraine were effective in reducing headaches in a pivotal study. (Source: Reuters: Health)
Source: Reuters: Health - December 17, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

All roads lead to migraine
(International Headache Society) Dr. Samaira Younis, from the Danish Headache Center in Copenhagen, Denmark, shares her research results, which suggests there are no differences between migraine attacks clinical characteristics following administration of 2 different compounds in patients, CGRP and sildenafil, meaning they share common cellular signaling pathways. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 16, 2019 Category: International Medicine & Public Health Source Type: news

Nightly sleep disturbance linked to daily risk of migraines
(Brigham and Women's Hospital) The team's findings generally support patients' reports of sleep disturbance as a trigger for migraines. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 16, 2019 Category: International Medicine & Public Health Source Type: news

A systematic review of structural and functional imaging correlates of headache or pain following mild traumatic brain injury - Ofoghi Z, Dewey D, Barlow KM.
In this study, we reviewed the existing literature examining structural differences in brain morphology and axonal connections, as w... (Source: SafetyLit)
Source: SafetyLit - December 14, 2019 Category: International Medicine & Public Health Tags: Research Methods, Surveillance and Codes, Models Source Type: news

CDC Estimates 1,300 Flu Deaths In US This Season; Widespread Activity In Massachusetts
(CNN/CBS) — At least 1,300 people have died from the flu so far this season, according to a preliminary estimate released Friday by the US Centers for Disease Control and Prevention. There have been at least 2.6 million flu illnesses and 23,000 flu-related hospitalizations, according to the analysis. So far this season, the CDC has received reports of 10 children who have died from the flu, four more than the week before. Experts have warned that flu is hitting the United States early this year, and there are concerns that this early season could mean a particularly severe season overall. Flu spread significantly in ...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - December 13, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Flu Source Type: news

Evidence Supports Use of High-Dose Aspirin for Migraine
FRIDAY, Dec. 13, 2019 -- Evidence supports the use of high-dose aspirin for treating acute migraine and low-dose aspirin for prevention of recurrent attacks, according to a review recently published in the American Journal of Medicine. Bianca... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 13, 2019 Category: Pharmaceuticals Source Type: news

Pediatric Migraine Guidelines Show Limits of Current Research Pediatric Migraine Guidelines Show Limits of Current Research
New guidelines on pharmacological treatment for pediatric migraine underscore the need for more research to help the one-third of children and adolescents who aren't helped by existing treatments, according to the authors of a new report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 12, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Running away from exercise: The curious case of migraine
(International Headache Society) In spite of the widespread recommendation for regular physical activity as a strategy to manage migraine, for some patients, exercise can instead trigger migraine attacks. Here, Samantha et al found that anxiety sensitivity mediates intentional avoidance of both moderate and vigorous physical activity. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 12, 2019 Category: International Medicine & Public Health Source Type: news

Medical News Today: Constipation and headaches at the same time
Sometimes, constipation and headaches can occur at the same time. Read on to learn about some of the conditions that can cause these two symptoms to occur together, plus how to treat them. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 11, 2019 Category: Consumer Health News Tags: Constipation Source Type: news